Riverside (California, US): Thirdhand Smoke (THS) refers to the residual pollutants from tobacco smoke that remain on surfaces and in dust after the tobacco has been smoked. It can linger on indoor surfaces indefinitely, exposing both smokers and nonsmokers to potentially harmful substances. A team led by researchers at the University of California, Riverside, found that acute exposure of the skin to THS elevates biomarkers associated with the initiation of skin diseases, such as contact dermatitis and psoriasis.
The study, published in eBioMedicine of 'The Lancet Family of Journals,' is the first to be performed on humans exposed dermally to THS. "We found exposure of human skin to THS initiates mechanisms of inflammatory skin disease and elevates urinary biomarkers of oxidative harm, which could lead to other diseases, such as cancer, heart disease, and atherosclerosis," said Shane Sakamaki-Ching, a former graduate student at UC Riverside who graduated with a doctoral degree in the cell, molecular, and developmental biology in March 2022.
"Alarmingly, acute dermal exposure to THS mimics the harmful effects of cigarette smoking," added Ching. The clinical investigation, which took place at UC San Francisco, involved the participation of 10 healthy, non-smokers who were 22 to 45 years old. For three hours, each participant wore clothing impregnated with THS and either walked or ran on a treadmill for at least 15 minutes each hour to induce perspiration and increase uptake of THS through the skin.
The participants did not know the clothing had THS. Blood and urine samples were then collected from the participants at regular intervals to identify protein changes and markers of oxidative stress induced by the THS. Control exposure participants wore clean clothing. "We found acute THS exposure caused elevation of urinary biomarkers of oxidative damage to DNA, lipids, and proteins, and these biomarkers remained high after the exposure stopped," said Sakamaki-Ching, now a research scientist at Kite Pharma in California, where he leads a stem cell team.